Replies to post #403175 on Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

Twice:
11/11/21 "Brilacidin did not show a difference compared to placebo in reducing Time to Sustained Recovery Through Day 29, the study’s primary endpoint based on clinical status."

4/17/24 "Warning! This security is traded on the Expert Market "